‘Non-Medical Switching’ Claim Riles Europe’s Biosimilars Industry

 
• By Ian Schofield
  
European countries
Two patient groups have concerns about "non-medical switching" of biosimilars in Europe

More from Biosimilars

More from Biosimilars & Generics